Clinical Trial Update: A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects [Phase 2]

View source ↗

Summary

Phase 2 study to assess the long-term effect of pramlintide on body weight in obese subjects; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Symlin (pramlintide) (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Obesity | Phase 2 | Status: COMPLETED